Cargando…
In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells
Aim. In Crohn's disease (CD), anti-TNF-α treatment is a potent medication. We aimed to characterize the effect of anti-TNF-α treatment on T effector and regulatory cells. Material and Methods. We studied T-effector and regulatory cells on cellular and mRNA levels in intestinal biopsy samples fr...
Autores principales: | Hölttä, Veera, Sipponen, Taina, Westerholm-Ormio, Mia, Salo, Harri M., Kolho, Kaija-Leena, Färkkilä, Martti, Savilahti, Erkki, Vaarala, Outi, Klemetti, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384926/ https://www.ncbi.nlm.nih.gov/pubmed/22778976 http://dx.doi.org/10.5402/2012/505432 |
Ejemplares similares
-
Dendritic Cells from Crohn’s Disease Patients Show Aberrant STAT1 and STAT3 Signaling
por: Nieminen, Janne K., et al.
Publicado: (2013) -
Lactose inhibits regulatory T-cell-mediated suppression of effector T-cell
interferon-γ and IL-17 production
por: Paasela, Monika, et al.
Publicado: (2014) -
Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa
por: Haveri, Hanna, et al.
Publicado: (2008) -
Markers of gut mucosal inflammation and cow’s milk specific immunoglobulins in non-IgE cow’s milk allergy
por: Merras-Salmio, Laura, et al.
Publicado: (2014) -
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)